Fibrin spray reduces blood loss vs standard electrocautery in THR .
Blood loss reduction in cementless total hip replacement with fibrin spray or bipolar sealer: a randomised controlled trial on ninety five patients
Int Orthop. 2013 Jul;37(7):1213-7. doi: 10.1007/s00264-013-1903-8. Epub 2013 May 18Ninety-five patients scheduled to undergo a total hip replacement were randomized to receive either a fibrin spray, a bipolar sealer or standard electrocautery (control group) to evaluate the effects of these interventions on blood conservation. Results indicated that fibrin spray significantly reduced blood loss compared to standard electrocautery at 6, 24, 48, and 72 hours. On the contrary, bipolar sealer only significantly reduced blood loss at the 48-hour mark compared to the control group. There were no adverse events reported.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
